Rubius Therapeutics, Inc.

JPMORGAN CHASE & CO

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/13/2023

Shares

2,196

Value ($000)

0

Weight

0.0%

2019 Q4 - 2022 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/13/2023	0	0.0%	2,196	12/31/2022
2022 Q3	11/14/2022	2	0.0%	5,757	9/30/2022
2022 Q2	8/11/2022	474	0.0%	556,869	6/30/2022
2022 Q1	5/11/2022	16,885	0.0%	3,064,499	3/31/2022
2021 Q4	2/11/2022	30,602	0.0%	3,161,516	12/31/2021
2021 Q3	11/12/2021	43,858	0.0%	2,452,869	9/30/2021
2021 Q2	8/12/2021	57,634	0.0%	2,361,088	6/30/2021
2021 Q1	5/12/2021	59,956	0.0%	2,262,499	3/31/2021
2020 Q4	2/19/2021	19,636	0.0%	2,587,122	12/31/2020
2020 Q3	11/12/2020	11,656	0.0%	2,308,274	9/30/2020
2020 Q2	8/11/2020	12,307	0.0%	2,058,037	6/30/2020
2020 Q1	5/12/2020	5,222	0.0%	1,173,574	3/31/2020
2019 Q4	2/11/2020	7,526	0.0%	792,152	12/31/2019